coronavirus October 26, 2021 6:52 am

FDA Panel Meets to Review Pfizer's COVID-19 Vaccine for Kids 5-11

A panel of U.S. health advisers Tuesday begins discussions on whether or not the FDA should grant emergency authorization to Pfizer’s COVID-19 vaccine for children ages 5 to 11. Thom Jensen reports.

US & World Videos

4:13

Oakland Deli hit by burglars 11 times since 2022
5:47

A conversation with San Francisco Mayor London Breed
2:43

In the news: Alleged racist attack, SJ mayor discusses proposed city budget, Bay Area sports royalty
2:51

Murder defendants reach plea deal in landmark case tied to Antioch police racist texts
1:39

Bicyclist struck, killed in San Jose; driver taken into custody
Exit mobile version